Organ transplantation requires careful evaluation of both the donor and recipient to maximize compatibility and minimize the risk of organ rejection. Organ Transplant Testing involves a series of genetic, immunological, and infectious disease screenings that help determine transplant suitability and support long-term transplant success.
Compatibility & Genetic Testing
These tests assess whether the donor organ is compatible with the recipient's immune system.
Blood Typing (ABO)
Determines the blood group of both donor and recipient to ensure compatibility before transplantation.
HLA Tissue Typing
Human Leukocyte Antigen (HLA) testing evaluates genetic similarities between donor and recipient. A closer match can improve transplant success and reduce rejection risks.
Crossmatch Testing
This test checks whether the recipient has antibodies that may attack the donor organ. A negative crossmatch result indicates that transplantation can safely proceed.
Panel Reactive Antibody (PRA) Testing
PRA testing measures the level of immune sensitization in the recipient and helps assess the likelihood of finding a compatible donor.
Infectious Disease & Cancer Screening
Since transplant recipients require immunosuppressive medications, it is essential to identify and manage any underlying infections or malignancies before transplantation.
Infectious Disease Screening
Comprehensive screening is performed for:
HIV ,
Hepatitis B & C ,
Cytomegalovirus (CMV) ,
Epstein-Barr Virus (EBV) ,
Tuberculosis (TB)
Cancer Screening
Routine cancer evaluations may include:
Colonoscopy ,
Mammography ,
Pap Smear ,
PSA Testing (for men) ,
Other age and risk-based screenings .
✔ Improved donor-recipient matching ✔ Reduced risk of organ rejection ✔ Early detection of infections and health risks ✔ Better transplant planning and outcomes ✔ Enhanced long-term patient care
Results are typically available within 2–3 weeks from sample collection.